PRL.MI WACC - Weighted Average Cost of Capital
The WACC of Pierrel SpA (PRL.MI) is 7.0%.
| Range | Selected | |
| Cost of equity | 6.8% - 8.6% | 7.7% |
| Tax rate | 7.7% - 8.9% | 8.3% |
| Cost of debt | 5.0% - 5.0% | 5% |
| WACC | 6.3% - 7.7% | 7.0% |
| Category | Low | High |
| Long-term bond rate | 3.7% | 4.2% |
| Equity market risk premium | 8.3% | 9.3% |
| Adjusted beta | 0.38 | 0.42 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.8% | 8.6% |
| Tax rate | 7.7% | 8.9% |
| Debt/Equity ratio | 0.28 | 0.28 |
| Cost of debt | 5.0% | 5.0% |
| After-tax WACC | 6.3% | 7.7% |
| Selected WACC | 7.0% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| PRL.MI | Pierrel SpA | 0.28 | 0.18 | 0.15 |
| ADVIC.PA | Advicenne SA | 0.26 | 1.25 | 1.01 |
| AMYT.L | Amryt Pharma Holdings Ltd | 0.34 | 0.05 | 0.04 |
| FCM.MI | Friulchem SpA | 2.72 | 0.15 | 0.04 |
| INDEX.ST | InDex Pharmaceuticals Holding AB | 0.01 | -0.92 | -0.91 |
| LAVI.AT | Lavipharm SA | 0.26 | 1.08 | 0.88 |
| MARI.VI | Marinomed Biotech AG | 0.83 | 0.13 | 0.07 |
| ORX.ST | Orexo AB | 0.89 | 0.14 | 0.08 |
| SHE.MI | Shedir Pharma Srl Unipersonale | 0.15 | -0.16 | -0.14 |
| VISTN.OL | Vistin Pharma ASA | 0.05 | 0.21 | 0.2 |
| Low | High | |
| Unlevered beta | 0.06 | 0.11 |
| Relevered beta | 0.07 | 0.13 |
| Adjusted relevered beta | 0.38 | 0.42 |
PRL.MI's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for PRL.MI:
cost_of_equity (7.70%) = risk_free_rate (3.95%) + equity_risk_premium (8.80%) * adjusted_beta (0.38) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.